enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ozempic Linked to Lower Alzheimer’s Risk in People with Type ...

   www.aol.com/ozempic-linked-lower-alzheimer-risk...

   Semaglutide, the active ingredient in Ozempic and Wegovy, may also help lower the risk of developing Alzheimer’s disease in people living with type 2 diabetes.

3. Semaglutide drugs may help keep Alzheimer's at bay - AOL

   www.aol.com/lifestyle/semaglutide-drugs-may-help...

   People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's disease, new evidence shows. Semaglutide drugs may help keep Alzheimer's at bay

4. Largest-ever Ozempic and GLP-1 drug study finds they lower ...

   www.aol.com/finance/largest-ever-ozempic-glp-1...

   A new study suggests that weight loss and diabetes treatment may represent only a small sample of the potential uses of GLP-1 drugs. ... (8%) and Alzheimer’s (12%)—not overwhelming, but still ...

5. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   A large study of more than 2 million people evaluated benefits and risks of GLP-1 agonists. The study showed that GLP-1 agonists reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimer’s disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions [5].

6. Prevention of dementia - Wikipedia

   en.wikipedia.org/wiki/Prevention_of_dementia

   Diabetes mellitus is a risk factor for vascular dementia, and is thus the risk is lowered with anti-diabetic drugs. [43] Besides, Rosiglitazone (Avandia) improves memory and thinking ability for people with mild Alzheimer's disease. The mechanism of the effect may be the ability of the drug to reduce insulin resistance. [10]

7. Type 3 diabetes - Wikipedia

   en.wikipedia.org/wiki/Type_3_diabetes

   Type 3 diabetes is a proposed pathological linkage between Alzheimer's disease and certain features of type 1 and type 2 diabetes. [1] Specifically, the term refers to a set of common biochemical and metabolic features seen in the brain in Alzheimer's disease, and in other tissues in diabetes; [1] [2] it may thus be considered a "brain-specific type of diabetes."